Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis

NCT01440309 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

UNKNOWN

Sponsor class

Conditions

Primary Biliary Cirrhosis

Interventions

BIOLOGICAL: Biological: mesenchymal stem cell
DRUG: ursodeoxycholic acid

Sponsor

Robert Chunhua Zhao, MD, PhD

Collaborators

[object Object]